N-(5-methylisoxazol-3-yl)-2-(6-((4-methylpiperidin-1-yl)sulfonyl)-4-oxoquinazolin-3(4H)-yl)acetamide结构式
|
常用名 | N-(5-methylisoxazol-3-yl)-2-(6-((4-methylpiperidin-1-yl)sulfonyl)-4-oxoquinazolin-3(4H)-yl)acetamide | 英文名 | N-(5-methylisoxazol-3-yl)-2-(6-((4-methylpiperidin-1-yl)sulfonyl)-4-oxoquinazolin-3(4H)-yl)acetamide |
|---|---|---|---|---|
| CAS号 | 850781-18-9 | 分子量 | 445.5 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C20H23N5O5S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-(5-methylisoxazol-3-yl)-2-(6-((4-methylpiperidin-1-yl)sulfonyl)-4-oxoquinazolin-3(4H)-yl)acetamide |
|---|
| 分子式 | C20H23N5O5S |
|---|---|
| 分子量 | 445.5 |
| InChIKey | SUGGNZVWLSALQI-UHFFFAOYSA-N |
| SMILES | CC1CCN(CC1)S(=O)(=O)C2=CC3=C(C=C2)N=CN(C3=O)CC(=O)NC4=NOC(=C4)C |
|
实验名称:Identification of CBX7 inhibitors - Primary Alpha Screen
来源:15290
靶标:N/A
External Id:CBX7-Alpha-primary
|